CICCACCI, CINZIA

CICCACCI, CINZIA

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

CICCACCI, CINZIA 

ex-Dipartimento di Biopatologia e Diagnostica per Immagini 

Pubblicazioni

Risultati 1 - 20 di 60 (tempo di esecuzione: 0.0 secondi).

Data di pubblicazioneTitoloAutore(i)TipoFile
1gen-2013ABCC10 rs2125739 polymorphism and nevirapine-induced hepatotoxicity: lack of association in a population from MozambiqueCiccacci, C; Di Fusco, D; Marazzi, M; Liotta, G; Palombi, L; Novelli, G; Borgiani, PArticolo su rivista  riservati
22016Advances in exploring the role of micrornas in inflammatory bowel diseaseCiccacci, C; Politi, C; Novelli, G; Borgiani, PArticolo su rivista  riservati
32007Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in ItaliansBorgiani, P; Ciccacci, C; Forte, V; Romano, S; Federici, G; Novelli, GArticolo su rivista-
42021Altered expression of miR-142, miR-155, miR-499a and of their putative common target MDM2 in systemic lupus erythematosusLatini, A; Ciccacci, C; De Benedittis, G; Novelli, L; Ceccarelli, F; Conti, F; Novelli, G; Perricone, C; Borgiani, PArticolo su rivista  riservati
5mar-2011Anthropological features of the CFTR gene: Its variability in an African populationCiminelli, B; Bombieri, C; Ciccacci, C; Belpinati, F; Pompei, F; Maselli, R; Simporé, J; Pignatti, P; Modiano, GArticolo su rivista-
62018Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetesCiccacci, C; Latini, A; Greco, C; Politi, C; D'Amato, C; Lauro, D; Novelli, G; Borgiani, P; Spallone, VArticolo su rivista  Solo autorizzati
72008ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian PopulationPerricone, C; Borgiani, P; Romano, S; Ciccacci, C; Fusco, G; Novelli, G; Biancone, L; Calabrese, E; Pallone, FArticolo su rivista-
82015Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's diseaseRufini, S; Ciccacci, C; Di Fusco, D; Ruffa, A; Pallone, F; Novelli, G; Biancone, L; Borgiani, PArticolo su rivista  riservati
92013Biomarkers to predict drug efficacy and safety in neurodegenerative diseasesNovelli, G; Abadie, E; Ciccacci, C; Di Fusco, D; Papaluca Amati, M; Borgiani, PArticolo su rivista-
102017Cannabinoid Poisoning by Hemp Seed Oil in a ChildChinello, M; Scommegna, S; Shardlow, A; Mazzoli, F; de Giovanni, N; Fucci, N; Borgiani, P; Ciccacci, C; Locasciulli, A; Calvani, MArticolo su rivista  riservati
112011Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patientCiccacci, C; Falconi, M; Paolillo, N; Oteri, F; Forte, V; Novelli, G; Desideri, A; Borgiani, PArticolo su rivista  riservati
122019A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetesLatini, A; Spallone, V; D'Amato, C; Novelli, G; Borgiani, P; Ciccacci, CArticolo su rivista  riservati
13ago-2014Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetesCiccacci, C; Morganti, R; Di Fusco, D; D'Amato, C; Cacciotti, L; Greco, C; Rufini, S; Novelli, G; Sangiuolo, F; Marfia, GA; Borgiani, P; Spallone, VArticolo su rivista  riservati
142015Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genesCiccacci, C; Rufini, S; Politi, C; Novelli, G; Forte, V; Borgiani, PArticolo su rivista  riservati
15feb-2009CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian populationBorgiani, P; Ciccacci, C; Forte, V; Sirianni, E; Novelli, L; Bramanti, P; Novelli, GArticolo su rivista-
162020The differential response to anti IL-6 treatment in COVID-19: the genetic counterpartPerricone, C; Conigliaro, P; Ciccacci, C; Marcucci, E; Cafaro, G; Bartoloni, E; Perricone, R; Novelli, G; Borgiani, P; Gerli, RArticolo su rivista  riservati
17giu-2019Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 IndividualsDanese, E; Raimondi, S; Montagnana, M; Tagetti, A; Langaee, T; Borgiani, P; Ciccacci, C; Carcas, Aj; Borobia, Am; Tong, Hy; Dávila-Fajardo, C; Rodrigues Botton, M; Bourgeois, S; Deloukas, P; Caldwell, Md; Burmester, Jk; Berg, Rl; Cavallari, Lh; Drozda, K; Huang, M; Zhao, L; Cen, H; Gonzalez-Conejero, R; Roldan, V; Nakamura, Y; Mushiroda, T; Gong, Iy; Kim, Rb; Hirai, K; Itoh, K; Isaza, C; Beltrán, L; Jiménez-Varo, E; Cañadas-Garre, M; Giontella, A; Kringen, Mk; Haug, Kbf; Gwak, Hs; Lee, Ke; Minuz, P; Lee, Mtm; Lubitz, Sa; Scott, S; Mazzaccara, C; Sacchetti, L; Genç, E; Özer, M; Pathare, A; Krishnamoorthy, R; Paldi, A; Siguret, V; Loriot, M; Kutala, Vk; Suarez-Kurtz, G; Perini, J; Denny, Jc; Ramirez, Ah; Mittal, B; Rathore, Ss; Sagreiya, H; Altman, R; Shahin, Mha; Khalifa, Si; Limdi, Na; Rivers, C; Shendre, A; Dillon, C; Suriapranata, Im; Zhou, H; Tan, S; Tatarunas, V; Lesauskaite, V; Zhang, Y; Maitland-van der Zee, Ah; Verhoef, Ti; de Boer, A; Taljaard, M; Zambon, Cf; Pengo, V; Zhang, Je; Pirmohamed, M; Johnson, Ja; Fava, CArticolo su rivista  riservati
182021Emerging role of microRNAs and long non-coding rnas in sjögren’s syndromeDe Benedittis, G; Ciccacci, C; Latini, A; Novelli, L; Novelli, G; Borgiani, PArticolo su rivista  riservati
19giu-2011EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian PopulationCiccacci, C; Paolillo, N; Di Fusco, D; Novelli, G; Borgiani, PArticolo su rivista  riservati
20ago-2018Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypesCiccacci, C; Perricone, C; Alessandri, C; Latini, A; Politi, C; Delunardo, F; Pierdominici, M; Conti, F; Novelli, G; Ortona, E; Borgiani, PArticolo su rivista  riservati
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2022